Never‐Treated, Non Splenectomised Patients With Gaucher Disease (The French GANT Study): The Prospective Follow‐Up
Journal of Inherited Metabolic Disease · 2025
DOI: 10.1002/jimd.70026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2025. Verfasst von Alberto Nasce und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetes, Nutrition, Geneva University Hospitals, Geneva, Switzerland. Hauptthemen laut MEDLINE: Gaucher Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Treatment options for Type 1 Gaucher Disease (GD1) include enzyme replacement therapy and oral substrate reduction therapy. The criteria for treatment initiation vary across regions. Recent retrospective studies have highlighted the natural progression of never‐treated GD1, suggesting that some patients remain asymptomatic or stable for extended periods. However, there is no data on long‐term prospective follow‐up. We conducted a prospective study following a cross‐sectional analysis of 36 never‐treated, non‐splenectomised GD1 patients from the French Gaucher Disease Registry (FGDR). The objective was to describe the natural disease progression, tracking clinical, radiological, and biological characteristics over time. Thirty‐six non‐splenectomised and never‐treated patients (19 women and 17 men) diagnosed with Gaucher Disease were prospectively followed for an additional median duration of 6.5 (5–8.3) years. Of the cohort, 17 remained untreated, 10 initiated treatment, and 7 were lost to follow‐up. Although never‐treated patients tended to be older at the time of first symptoms, diagnosis, and last follow‐up compared to those who received treatment, the difference was not significant in this small cohort. At last follow‐up, never‐treated patients had no worsening of most of their symptoms. No significant changes were observed in platelets, chitotriosidase, and lyso‐Gb1. In this prospective cohort, we highlight that patients with mild GD can remain untreated with no disease progression, offering insights into cost‐effective management strategies. Identifying such patients is still challenging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, Diabetes, Nutrition, Geneva University Hospitals, Geneva, Switzerland.
- Department of Internal Medicine, Reference Center for Lysosomal Diseases, AP-HP Nord, Paris Cité University, Beaujon Hospital, Paris, France.
- Center for Epidemiology and Statistics, Université Paris Cité (CRESS), INSERM U1153, Paris, France.
- Department of Internal Medicine, Haut Lévêque Hospital, Bordeaux University Hospital, Pessac, France.
- Biochemical and Molecular Biology Department, Centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, Bron, France.
- Institute of Cancerology and Hematology, CHRU Morvan, Brest, France.
ORCID-Profile: Christine Serratrice
Zitieren
APA
Nasce, A., Nguyen, Y., Belmatoug, N., Yousfi, K., Camou, F., Pettazzoni, M., Dalbies, F., Cador, B., Brassier, A., Pichard, S., Hivert, B., Swiader, L., Bertchansky, I., Seguin, V. L., Mauhin, W., Astudillo, L., Rainsard, I. H., Humbert, S., Hoebeke, C., …, & Comité d'Evaluation et de Traitement de la maladie de Gaucher (CETG) (2025). Never‐Treated, Non Splenectomised Patients With Gaucher Disease (The French GANT Study): The Prospective Follow‐Up. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70026
Vancouver
Nasce A, Nguyen Y, Belmatoug N, Yousfi K, Camou F, Pettazzoni M, et al. Never‐Treated, Non Splenectomised Patients With Gaucher Disease (The French GANT Study): The Prospective Follow‐Up. Journal of Inherited Metabolic Disease. 2025. doi:10.1002/jimd.70026
BibTeX
@article{Nasce2025,
author = {Nasce, Alberto and Nguyen, Yann and Belmatoug, Nadia and Yousfi, Karima and Camou, Fabrice and Pettazzoni, Magali and Dalbies, Florence and Cador, Bérengère and Brassier, Anaïs and Pichard, Samia and Hivert, Bénédicte and Swiader, Laure and Bertchansky, Ivan and Seguin, Vanessa Leguy and Mauhin, Wladimir and Astudillo, Leonardo and Rainsard, Isabelle Hau and Humbert, Sébastien and Hoebeke, Celia and Hamroun, Dalil and Masseau, Agathe and Berger, Marc G and Stirnemann, Jérôme and Serratrice, Christine and Comité d'Evaluation et de Traitement de la maladie de Gaucher (CETG), Comité d'Evaluation et de Traitement de la maladie de Gaucher (CETG)},
title = {Never‐Treated, Non Splenectomised Patients With Gaucher Disease (The French GANT Study): The Prospective Follow‐Up},
journal = {Journal of Inherited Metabolic Disease},
year = {2025},
doi = {10.1002/jimd.70026}
}
EUVIMED